State Street Corp Nant Health, Inc. Transaction History

State Street Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.42 - $0.78 $168,393 - $312,730	-400,937 Reduced 76.67%	122,016 $51,000
Q1 2022 May 16, 2022	BUY	$0.75 - $1.08 $11,414 - $16,436	15,219 Added 3.0%	522,953 $394,000
Q4 2021 Feb 14, 2022	BUY	$0.94 - $1.85 $20,491 - $40,328	21,799 Added 4.49%	507,734 $536,000
Q3 2021 Nov 15, 2021	BUY	$1.61 - $2.41 $25,315 - $37,894	15,724 Added 3.34%	485,935 $782,000
Q2 2021 Aug 16, 2021	BUY	$2.25 - $3.37 $72,353 - $108,369	32,157 Added 7.34%	470,211 $1.09 Million
Q1 2021 May 17, 2021	BUY	$3.0 - $5.1 $9,153 - $15,560	3,051 Added 0.7%	438,054 $1.41 Million
Q4 2020 Feb 16, 2021	BUY	$1.96 - $3.56 $24,015 - $43,620	12,253 Added 2.9%	435,003 $1.41 Million
Q3 2020 Nov 10, 2020	BUY	$2.1 - $5.99 $12,694 - $36,209	6,045 Added 1.45%	422,750 $989,000
Q2 2020 Aug 14, 2020	BUY	$1.45 - $4.99 $589,577 - $2.03 Million	406,605 Added 4025.79%	416,705 $1.91 Million
Q1 2020 May 11, 2020	BUY	$0.97 - $2.27 $9,797 - $22,927	10,100 New	10,100 $16,000

Ticker NH
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 115,550,000
Market Cap $48.5M
Description
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Ev...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.